Antibody-engineering strategies for improving CNS biotherapeutic delivery, offering practical translational design and cross-species testing guidance for researchers planning preclinical evaluation.
Key Takeaways
- We developed CD98hc-targeted central nervous system (CNS)
- These bispecific antibodies achieve efficient and sustained brain delivery
- Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle